Bachurski, Patryk, Gabriela Chmiel, Paweł Kalinowski, Maja Międlar, Martyna Muda, Szymon Pacek, Elisabetta Pierzga, Karol Wiśniewski, Paweł Witkowski, and Bartosz Zarański. 2026. “Optimal First-Line Use of Pembrolizumab in Metastatic Driver-Negative NSCLC: Monotherapy Versus Chemo-Immunotherapy (Evidence 2022–2025)”. Quality in Sport 51 (January):68252. https://doi.org/10.12775/QS.2026.51.68252.